Cargando…

Epidemiological Survey on the Perception of Adverse Effects in Women Using Contraceptive Methods in Brazil

Objective  The present study aimed to understand patient perception of the adverse effects of contraceptives to improve health care and adherence to treatment. Methods  An online questionnaire was available for women in Brazil to respond to assess their perception of adverse effects and their relati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pannain, Gabriel Duque, Brum, Vivian de Oliveira Rodrigues, Abreu, Maria Mariana Andrade, Lima, Gabriela Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948235/
https://www.ncbi.nlm.nih.gov/pubmed/35092956
http://dx.doi.org/10.1055/s-0041-1741410
Descripción
Sumario:Objective  The present study aimed to understand patient perception of the adverse effects of contraceptives to improve health care and adherence to treatment. Methods  An online questionnaire was available for women in Brazil to respond to assess their perception of adverse effects and their relationship with contraceptive methods. Results  Of all 536 women who responded, 346 (64.6%) reported current contraceptive use. One hundred and twenty-two (122–34.8%) women reported having already stopped using contraception because of the adverse effects. As for the contraceptive method used, the most frequent was the combined oral contraceptive (212–39.6%). When we calculated the relative risk for headache, there was a relative risk of 2.1282 (1.3425–3.3739; 95% CI), suggesting that the use of pills increases the risk of headache, as well as edema, in which a relative risk of 1.4435 (1.0177–2.0474; 95% CI) was observed. For low libido, the use of oral hormonal contraceptives was also shown to be a risk factor since its relative risk was 1.8805 (1.3527–2.6142; 95% CI). As for acne, the use of hormonal contraceptives proved to be a protective factor, with a relative risk of 0.3015 (0.1789–0.5082; 95% CI). Conclusion  The choice of a contraceptive method must always be individualized, and the patients must be equal participants in the process knowing the expected benefits and harms of each method and hormone, when present.